missing translation for 'onlineSavingsMsg'
Learn More
Learn More
DiscoverX PathHunter™ TACR3 Activated GPCR Internalization U2OS Cell Line
Click to view available options
Quantity:
2 Vials
Unit Size:
2 ampoules
Description
The PathHunter™ TACR3 Activated GPCR internalization cell line is a stable, engineered cell line for use in studying drug candidates (small molecules or biologics) affecting GPCR activation and internalization. This cell line enables assessment of ligand (e.g. neurokinins, senkitide, substance P) based internalization of TACR3 via detection of localization to the early endosome. This product uses EFC technology. The included cell line overexpresses EA-tagged β-arrestin 2 as well as a PK-tagged early endosome protein and untagged TACR3. Upon ligand-induced receptor activation, β-arrestin 2 is recruited to the activated GPCR and the resulting TACR3-arrestin complex is internalized to the early endosome, leading to production of EFC signal. This stable modified cell line is provided as two vials of cryopreserved cells.
Specifications
Specifications
| Assay Entry | Receptor Internalization |
| Cell Line | U2OS |
| For Use With (Application) | Cell Lines |
| Primary Agonist | Senktide, [Succinyl-Asp6, NMephe8]-Substance P (6-11) |
| Quantity | 2 Vials |
| Target Entry | TACR3 |
| Accession Number | NM_001059 |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction